Vivos Therapeutics
Price & Volume
Stats
See more52W Range | $1.91-$48.79 |
Market Cap | $15.2M |
Shares Short | 95,088 |
Financials
See moreRevenue (12 Mos) | $14M |
Revenue Growth (YoY) | 19.4% |
Gross Profit (12 Mos) | $12.6M |
Diluted EPS | -$6.80 |
News
See moreYahoo Finance • 12 months ago
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Yahoo Finance • last year
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
Yahoo Finance • last year
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
Yahoo Finance • last year
Vivos Therapeutics Closes $4 Million Private Placement
About
CEO | Mr. R. Kirk Huntsman |
CFO | Mr. Bradford K. Amman |
Address | 7921 Southpark Plaza, Littleton, CO, United States, 80120 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 114 |
